• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测量严重哮喘肺部外症状的问卷的初步开发。

Preliminary development of a questionnaire to measure the extra-pulmonary symptoms of severe asthma.

机构信息

Sapienza University of Rome, Rome, Italy.

NC IUL University, London, UK.

出版信息

BMC Pulm Med. 2021 Nov 14;21(1):369. doi: 10.1186/s12890-021-01730-0.

DOI:10.1186/s12890-021-01730-0
PMID:34775957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8591792/
Abstract

BACKGROUND

Research into the effects of asthma treatments on the extra-pulmonary symptoms of severe asthma is limited by the absence of a suitable questionnaire. The aim was to create a questionnaire suitable for intervention studies by selecting symptoms that are statistically associated with asthma pathology and therefore may improve when pathology is reduced.

METHODS

Patients attending a specialist asthma clinic completed the 65-item General Symptom Questionnaire (GSQ-65), a questionnaire validated for assessing symptoms of people with multiple medically unexplained symptoms. Lung function (FEV1%) and cumulative oral corticosteroids (OCS) calculated from maintenance dose plus exacerbations were obtained from clinic records. Pathology was represented by the two components of a principal component analysis (PCA) of FEV1% and OCS. LASSO regression was used to select symptoms that had high coefficients with these two principal components and occurred frequently in severe asthma.

RESULTS

100 patients provided data. PCA revealed two components, one where FEV1% and OCS were inversely related and another where they were directly related. LASSO regression revealed 39 symptoms with non-zero coefficients on one or more of the two principal components from which 16 symptoms were selected for the GSQ-A on the basis of magnitude of coefficient and frequency. Asthma symptoms measured by asthma control questionnaires were excluded. The GSQ-A correlated 0.33 and - 0.34 (p = 0.001) with the two principal components.

CONCLUSION

The GSQ-A assesses the frequency of 16 heterogenous non-respiratory symptoms that are associated with asthma severity using the statistical combination of FEV1% and OCS.

摘要

背景

由于缺乏合适的问卷,对哮喘治疗对严重哮喘的肺外症状的影响的研究受到限制。目的是通过选择与哮喘病理统计学相关的症状来创建适合干预研究的问卷,因此当病理减轻时这些症状可能会改善。

方法

在专科哮喘诊所就诊的患者完成了 65 项一般症状问卷(GSQ-65),该问卷经过验证,可用于评估患有多种医学无法解释的症状的人群的症状。从就诊记录中获得肺功能(FEV1%)和累积口服皮质类固醇(OCS),由维持剂量加加重期计算得出。病理表现为 FEV1%和 OCS 的主成分分析(PCA)的两个组成部分。使用 LASSO 回归选择与这两个主要成分高度相关且在严重哮喘中经常发生的症状。

结果

100 名患者提供了数据。PCA 显示了两个组成部分,一个是 FEV1%和 OCS 呈反比关系,另一个是 FEV1%和 OCS 呈正相关。LASSO 回归显示,有 39 个症状在一个或多个主要成分上具有非零系数,其中 16 个症状基于系数的大小和频率被选为 GSQ-A。哮喘控制问卷测量的哮喘症状被排除在外。GSQ-A 与两个主要成分的相关性为 0.33 和 -0.34(p=0.001)。

结论

GSQ-A 使用 FEV1%和 OCS 的统计组合评估了与哮喘严重程度相关的 16 种异质非呼吸症状的频率。

相似文献

1
Preliminary development of a questionnaire to measure the extra-pulmonary symptoms of severe asthma.测量严重哮喘肺部外症状的问卷的初步开发。
BMC Pulm Med. 2021 Nov 14;21(1):369. doi: 10.1186/s12890-021-01730-0.
2
Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma.比较严重哮喘患者肺部和非肺部症状对健康相关生活质量的影响。
Respir Med. 2020 Feb;162:105870. doi: 10.1016/j.rmed.2020.105870. Epub 2020 Jan 10.
3
Association Between Pulmonary Function and Asthma Symptoms.肺功能与哮喘症状的关系。
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2319-2325. doi: 10.1016/j.jaip.2019.04.019. Epub 2019 Apr 26.
4
Evidence for similarity in symptoms and mechanism: The extra-pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia.有证据表明症状和机制存在相似性:严重哮喘的肺外症状和纤维肌痛的多症状表现。
Immun Inflamm Dis. 2019 Dec;7(4):239-249. doi: 10.1002/iid3.263. Epub 2019 Aug 23.
5
The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis.口服皮质类固醇对稳定期哮喘患者肺功能、2 型生物标志物和患者报告结局的影响:系统评价和荟萃分析。
Respir Med. 2020 Nov;173:106156. doi: 10.1016/j.rmed.2020.106156. Epub 2020 Sep 14.
6
Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients.每周自我测量 FEV1 和 PEF 及其对 ACQ(哮喘控制问卷)评分的影响:76 例患者的 12 周观察性研究。
NPJ Prim Care Respir Med. 2017 Dec 8;27(1):64. doi: 10.1038/s41533-017-0064-4.
7
Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?哮喘和慢性阻塞性肺疾病急性加重期肺功能下降——能否在不进行肺量计检查的情况下进行评估?
Int J Chron Obstruct Pulmon Dis. 2016 Dec 8;11:3145-3152. doi: 10.2147/COPD.S123315. eCollection 2016.
8
Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.一秒用力呼气容积与用力肺活量的支气管扩张剂反应、慢性阻塞性肺疾病加重和死亡率的关系。
Ann Am Thorac Soc. 2019 Jul;16(7):826-835. doi: 10.1513/AnnalsATS.201809-601OC.
9
Evaluation of a short form for measuring health-related quality of life among pediatric asthma patients.评估一种用于测量小儿哮喘患者健康相关生活质量的简表。
J Allergy Clin Immunol. 2000 Feb;105(2 Pt 1):245-51. doi: 10.1016/s0091-6749(00)90072-1.
10
Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.一种新型哮喘发作风险评分的制定与验证:发作风险评分。
J Allergy Clin Immunol. 2015 Jun;135(6):1457-64.e4. doi: 10.1016/j.jaci.2014.08.015. Epub 2014 Sep 23.

引用本文的文献

1
A lifestyle educational course as an adjunct to biologic administration in patients with severe asthma: A feasibility study.一项生活方式教育课程作为重度哮喘患者生物制剂治疗辅助手段的可行性研究。
PEC Innov. 2024 Dec 18;6:100364. doi: 10.1016/j.pecinn.2024.100364. eCollection 2025 Jun.

本文引用的文献

1
Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation.哮喘与肥胖:两种呈上升趋势且由炎症相联系的疾病。
J Clin Med. 2021 Jan 6;10(2):169. doi: 10.3390/jcm10020169.
2
Information Transfer in Linear Multivariate Processes Assessed through Penalized Regression Techniques: Validation and Application to Physiological Networks.通过惩罚回归技术评估线性多变量过程中的信息传递:验证及在生理网络中的应用
Entropy (Basel). 2020 Jul 1;22(7):732. doi: 10.3390/e22070732.
3
Fibromyalgia in Iraqi patients with asthma and its impact on asthma severity and control.伊拉克哮喘患者中的纤维肌痛及其对哮喘严重程度和控制的影响。
Ann Med Surg (Lond). 2020 Oct 16;60:22-26. doi: 10.1016/j.amsu.2020.10.019. eCollection 2020 Dec.
4
Evidence for similarity in symptoms and mechanism: The extra-pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia.有证据表明症状和机制存在相似性:严重哮喘的肺外症状和纤维肌痛的多症状表现。
Immun Inflamm Dis. 2019 Dec;7(4):239-249. doi: 10.1002/iid3.263. Epub 2019 Aug 23.
5
Symptom frequency and development of a generic functional disorder symptom scale suitable for use in studies of patients with irritable bowel syndrome, fibromyalgia syndrome or chronic fatigue syndrome.适用于肠易激综合征、纤维肌痛综合征或慢性疲劳综合征患者研究的通用功能性障碍症状量表的症状频率及编制
Chronic Dis Transl Med. 2019 Jun 24;5(2):129-138. doi: 10.1016/j.cdtm.2019.05.003. eCollection 2019 Jun.
6
The construction and validation of the Severe Asthma Questionnaire.《严重哮喘问卷》的编制与验证。
Eur Respir J. 2018 Jul 11;52(1). doi: 10.1183/13993003.00618-2018. Print 2018 Jul.
7
A test of the adaptive network explanation of functional disorders using a machine learning analysis of symptoms.一项使用症状机器学习分析对功能障碍适应性网络解释的测试。
Biosystems. 2018 Mar;165:22-30. doi: 10.1016/j.biosystems.2017.12.010. Epub 2017 Dec 24.
8
Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation.难治性哮喘中的共病“可治疗特征”:当前证据和临床评估。
Allergy. 2018 Jul;73(7):1369-1382. doi: 10.1111/all.13370. Epub 2017 Dec 15.
9
Fibromyalgia as a cause of uncontrolled asthma: a case-control multicenter study.
Curr Med Res Opin. 2017 Dec;33(12):2181-2186. doi: 10.1080/03007995.2017.1354828. Epub 2017 Aug 11.
10
Association of systemic inflammation, adiposity, and metabolic dysregulation with asthma burden among Hispanic adults.西班牙裔成年人中全身炎症、肥胖和代谢失调与哮喘负担的关联。
Respir Med. 2017 Apr;125:72-81. doi: 10.1016/j.rmed.2017.03.003. Epub 2017 Mar 6.